dc.contributor.author | Knudtzon, Stephanie | |
dc.contributor.author | Nordengen, Kaja | |
dc.contributor.author | Grøntvedt, Gøril Rolfseng | |
dc.contributor.author | Jarholm, Jonas Alexander | |
dc.contributor.author | Eliassen, Ingvild Vøllo | |
dc.contributor.author | Selnes, Per | |
dc.contributor.author | Pålhaugen, Lene | |
dc.contributor.author | Espenes, Johan Jacob | |
dc.contributor.author | Gisladottir, Berglind | |
dc.contributor.author | Waterloo, Knut K | |
dc.contributor.author | Fladby, Tormod | |
dc.contributor.author | Kirsebom, Bjørn-Eivind Seljelid | |
dc.date.accessioned | 2024-09-25T07:40:23Z | |
dc.date.available | 2024-09-25T07:40:23Z | |
dc.date.issued | 2024-06-04 | |
dc.description.abstract | Cerebrospinal fluid total-tau (t-tau) and neurofilament light chain (NfL) are biomarkers of neurodegeneration and are increased in Alzheimer’s disease (AD). In order to adjust for age-related increases in t-tau and NfL, cross-sectional age-adjusted norms were developed based on amyloid negative cognitively normal (CN) adults aged 41–78 years (CN, n = 137). The age-adjusted norms for t-tau and NfL did not improve receiver operating curve based diagnostic accuracies in individuals with mild cognitive impairment (MCI) due to AD (AD-MCI, n = 144). Furthermore, while NfL was correlated with higher age in AD-MCI, no significant correlation was found for t-tau. The cox proportional hazard models, applied in 429 participants with baseline t-tau and NfL, showed higher hazard ratio of progression to MCI or dementia without age-adjustments (HR = 3.39 for t-tau and HR = 3.17 for NfL), as compared to using our norms (HR = 2.29 for t-tau and HR = 1.89 for NfL). Our results indicate that utilizing normative reference data could obscure significant age-related increases in these markers associated with neurodegeneration and AD leading to a potential loss of overall diagnostic accuracy. | en_US |
dc.identifier.citation | Knudtzon, Nordengen, Grøntvedt, Jarholm, Eliassen, Selnes, Pålhaugen, Espenes, Gisladottir, Waterloo, Fladby, Kirsebom. Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer’s Disease. Neurobiology of Aging. 2024 | en_US |
dc.identifier.cristinID | FRIDAID 2273335 | |
dc.identifier.doi | 10.1016/j.neurobiolaging.2024.05.016 | |
dc.identifier.issn | 0197-4580 | |
dc.identifier.issn | 1558-1497 | |
dc.identifier.uri | https://hdl.handle.net/10037/34852 | |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.journal | Neurobiology of Aging | |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2024 The Author(s) | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | en_US |
dc.rights | Attribution 4.0 International (CC BY 4.0) | en_US |
dc.title | Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer’s Disease | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |